Stage IIB Skin Melanoma Completed Phase Trials for Fluorescein (DB00693)

IndicationStatusPhase
DBCOND0054560 (Stage IIB Skin Melanoma)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02857374Intravital Microscopy in Identifying Tumor Vessels in Patients With Stage IB-IIIC Melanoma Undergoing Sentinel Lymph Node BiopsyDiagnostic
NCT01886235Intravital Microscopy for Identifying Tumor Vessels in Patients With Stage IA-IV Melanoma That is Being Removed by SurgeryDiagnostic